Compare CUZ & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CUZ | LIVN |
|---|---|---|
| Founded | 1958 | 1987 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 3.5B |
| IPO Year | N/A | 1993 |
| Metric | CUZ | LIVN |
|---|---|---|
| Price | $25.75 | $62.98 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 8 |
| Target Price | $31.10 | ★ $65.00 |
| AVG Volume (30 Days) | ★ 1.4M | 572.1K |
| Earning Date | 02-05-2026 | 11-05-2025 |
| Dividend Yield | ★ 4.97% | N/A |
| EPS Growth | ★ 3.48 | N/A |
| EPS | ★ 0.35 | N/A |
| Revenue | $955,949,000.00 | ★ $1,348,962,000.00 |
| Revenue This Year | $14.95 | $12.25 |
| Revenue Next Year | $2.68 | $6.75 |
| P/E Ratio | $74.17 | ★ N/A |
| Revenue Growth | ★ 15.46 | 8.63 |
| 52 Week Low | $24.07 | $32.48 |
| 52 Week High | $31.36 | $65.57 |
| Indicator | CUZ | LIVN |
|---|---|---|
| Relative Strength Index (RSI) | 56.45 | 59.60 |
| Support Level | $24.82 | $61.79 |
| Resistance Level | $25.52 | $63.69 |
| Average True Range (ATR) | 0.49 | 1.38 |
| MACD | 0.13 | -0.36 |
| Stochastic Oscillator | 96.58 | 32.50 |
Cousins Properties Inc is a real estate investment trust principally involved in the ownership, management, and development of properties in the Southern United States. Cousins Properties' real estate portfolio mainly comprises offices and mixed-use developments that encompass both apartment and retail space. Offices make up the vast majority of the portfolio in terms of total square footage. The segments operates in following geographical areas: Atlanta, Austin, Charlotte, Dallas, Phoenix, Tampa, and other markets. The company derives nearly all of its revenue in the form of rental income from its properties, the majority of which comes from its office locations. A diverse set of tenants in the cities of Houston and Atlanta represent the company's key markets.
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.